Concentrum Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Concentrum Wealth Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-15,659	Closed	-$2.63M	–	41
2020 Q2	$2.63M	Buy	+15,659	New	+$2.46M	2.66%	9
2020 Q1	–	Sell	-3,308	Closed	-$492K	–	37
2019 Q4	$492K	Hold	3,308	–	–	0.55%	22
2019 Q3	$409K	Buy	3,308 +195	+6%	+$26K	0.52%	22
2019 Q2	$438K	Buy	3,113 +1,305	+72%	+$180K	0.52%	18
2019 Q1	$273K	Buy	1,808 +188	+12%	+$27.1K	0.36%	24
2018 Q4	$201K	Buy	+1,620	New	+$222K	0.34%	27

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Concentrum Wealth Management's FBT Position: Q3 2020 in Review

Concentrum Wealth Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2020, closing a stake of 15,659 shares — an estimated $2.63M sold.

Concentrum Wealth Management first reported a position in FBT in Q4 2018 and held it in 6 quarters. The position peaked at $2.63M in Q2 2020. 213 funds tracked by Wall St. Rank hold FBT as of Q3 2020.

Concentrum Wealth Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2020 after selling out during the quarter.
Concentrum Wealth Management sold 15,659 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2020, an estimated $2.63M.
Concentrum Wealth Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2018 and held it in 6 quarters.
Concentrum Wealth Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $2.63M in Q2 2020.
213 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2020.

Based on Concentrum Wealth Management's 13F filing for Q3 2020, filed 23 Oct 2020.